Company
Allogenetics
We create an immunological invisibility of the donor organ instead of inducing immunological blindness in the organ recipient.
- Business model
- B2B
- Legal name
- Allogenetics GmbH
Claim, correct or request removal
Record updated 28 September 2026
About
Allogenetics’ mission is to enable longer and healthier lives for transplant patients by fine-tuning the balance between host immune tolerance and protection. We are advancing an ex vivo gene therapy designed as a one-time treatment to modify the donor organ. Our goal is to eliminate the need for lifelong immunosuppression and its challenges to improve graft survival and patient quality of life.
Loading relationship preview